Polomar Health Services, Inc. (PMHS)
OTCMKTS · Delayed Price · Currency is USD
0.4216
0.00 (0.00%)
Aug 8, 2025, 4:00 PM EDT
Ligand Pharmaceuticals Market Cap
Polomar Health Services has a market cap or net worth of $11.66 million as of August 8, 2025.
Market Cap
11.66M
Enterprise Value
12.84M
Revenue
49.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since October 15, 2024, Polomar Health Services's market cap has decreased from 16.08M to 11.66M, a decrease of -27.50%. That is a compound annual growth rate of -36.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 11.66M | 499.72% |
| Dec 30, 2024 | 1.94M | -87.91% |
| Oct 15, 2024 | 16.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 474.59M |
| Spruce Biosciences | 427.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |